Summary

The global market for Microphysiological System was valued at US$ 126.41 million in 2024 and is forecast to a readjusted size of US$ 370.31 million by 2031 with a CAGR of 16.23% during the forecast period 2025-2031.
North American market for Microphysiological System was valued at $ 55.17 million in 2024 and will reach $ 154.43 million by 2031, at a CAGR of 15.34% during the forecast period of 2025 through 2031.
Asia-Pacific market for Microphysiological System was valued at $ 15.07 million in 2024 and will reach $ 53.72 million by 2031, at a CAGR of 19.58% during the forecast period of 2025 through 2031.
Europe market for Microphysiological System was valued at $ 51.79 million in 2024 and will reach $ 147.69 million by 2031, at a CAGR of 15.83% during the forecast period of 2025 through 2031.

The global key companies of Microphysiological System include Emulate, Mimetas, InSphero, TissUse, CN Bio, Valo Health (TARA Biosystems), Hesperos, TNO, 28bio, Newcells Biotech, etc. In 2024, the global five largest players hold a share approximately 48.81% in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Microphysiological System, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Microphysiological System by region & country, by Type, and by End User.
The Microphysiological System market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microphysiological System.

Market Segmentation

By Company
Emulate
Mimetas
TissUse
InSphero
Hesperos
CN Bio
TNO
28bio
Beijing Daxiang Biotech
Newcells Biotech
Nortis (Quris-Al)
Valo Health (TARA Biosystems)
Altis Biosystems
Draper Laboratory
Netri
Bi/ond
ImmuONE
AlveoliX
Cherry Biotech
Ananda Devices
Obatala Sciences
BiomimX
React4life
Aracari Bio
StemPharm
SynVivo

Segment by Type
Human Organ and Tissue Models
Disease Models
Non-Human Species Models

Segment by End User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others

By Region
North America
United States
Canada

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific

Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe

Latin America
Mexico
Brazil
Rest of Latin America

Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Microphysiological System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Microphysiological System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Microphysiological System in country level. It provides sigmate data by Type, and by End User for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview 1
1.1 Microphysiological System Product Introduction 1
1.2 Global Microphysiological System Market Size Forecast (2020-2031) 2
1.3 Microphysiological System Market Trends & Drivers 3
1.3.1 Microphysiological System Industry Trends 3
1.3.2 Microphysiological System Market Drivers & Opportunity 4
1.3.3 Microphysiological System Market Challenges 6
1.3.4 Microphysiological System Market Restraints 7
1.4 Government Policy Support for The Industry 8
1.5 Comparison of Related Technologies 10
1.6 Assumptions and Limitations 12
1.7 Study Objectives 13
1.8 Years Considered 14
2 Competitive Analysis by Company 15
2.1 Global Microphysiological System Players Revenue Ranking (2024) 15
2.2 Global Microphysiological System Revenue by Company (2020-2025) 17
2.3 Key Companies Microphysiological System Headquarters and Sales Area 19
2.4 Key Companies Microphysiological System Product Offered 21
2.5 Establish Date of Key Microphysiological System Companies 22
2.6 Microphysiological System Market Competitive Analysis 23
2.6.1 Microphysiological System Market Concentration Rate (2020-2025) 23
2.6.2 Global 3 and 5 Largest Companies by Microphysiological System Revenue in 2024 24
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microphysiological System as of 2024) 25
2.7 Mergers & Acquisitions, Expansion 26
3 Segmentation by Type 37
3.1 Introduction by Type 37
3.1.1 Human Organ and Tissue Models 37
3.1.2 Disease Models 39
3.1.3 Non-Human Species Models 40
3.2 Global Microphysiological System Sales Value by Type 41
3.2.1 Global Microphysiological System Sales Value by Type (2020 VS 2024 VS 2031) 42
3.2.2 Global Microphysiological System Sales Value, by Type (2020-2031) 44
3.2.3 Global Microphysiological System Sales Value, by Type (%) (2020-2031) 44
4 Segmentation by End User 46
4.1 Introduction by End User 46
4.1.1 Pharmaceutical & Biotechnology Companies 46
4.1.2 Academic & Research Institutes 48
4.1.3 Others 49
4.2 Global Microphysiological System Sales Value by End User 50
4.2.1 Global Microphysiological System Sales Value by End User (2020 VS 2024 VS 2031) 51
4.2.2 Global Microphysiological System Sales Value, by End User (2020-2031) 53
4.2.3 Global Microphysiological System Sales Value, by End User (%) (2020-2031) 53
5 Segmentation by Region 55
5.1 Global Microphysiological System Sales Value by Region 55
5.1.1 Global Microphysiological System Sales Value by Region: 2020 VS 2024 VS 2031 55
5.1.2 Global Microphysiological System Sales Value by Region (2020-2025) 55
5.1.3 Global Microphysiological System Sales Value by Region (2026-2031) 56
5.1.4 Global Microphysiological System Sales Value by Region (%), (2020-2031) 56
5.2 North America 58
5.2.1 North America Microphysiological System Sales Value, 2020-2031 58
5.2.2 North America Microphysiological System Sales Value by Country (%), 2024 VS 2031 59
5.3 Europe 60
5.3.1 Europe Microphysiological System Sales Value, 2020-2031 60
5.3.2 Europe Microphysiological System Sales Value by Country (%), 2024 VS 2031 61
5.4 Asia Pacific 62
5.4.1 Asia Pacific Microphysiological System Sales Value, 2020-2031 62
5.4.2 Asia Pacific Microphysiological System Sales Value by Region (%), 2024 VS 2031 63
5.5 Latin America 64
5.5.1 Latin America Microphysiological System Sales Value, 2020-2031 64
5.5.2 South America Microphysiological System Sales Value by Country (%), 2024 VS 2031 65
5.6 Middle East & Africa 66
5.6.1 Middle East & Africa Microphysiological System Sales Value, 2020-2031 66
5.6.2 Middle East & Africa Microphysiological System Sales Value by Country (%), 2024 VS 2031 67
6 Segmentation by Key Countries/Regions 68
6.1 Key Countries/Regions Microphysiological System Sales Value Growth Trends, 2020 VS 2024 VS 2031 68
6.2 Key Countries/Regions Microphysiological System Sales Value, 2020-2031 69
6.3 United States 73
6.3.1 United States Microphysiological System Sales Value, 2020-2031 73
6.3.2 United States Microphysiological System Sales Value by Type (%), 2024 VS 2031 74
6.3.3 United States Microphysiological System Sales Value by End User, 2024 VS 2031 75
6.4 Europe 76
6.4.1 Europe Microphysiological System Sales Value, 2020-2031 76
6.4.2 Europe Microphysiological System Sales Value by Type (%), 2024 VS 2031 77
6.4.3 Europe Microphysiological System Sales Value by End User, 2024 VS 2031 78
6.5 China 79
6.5.1 China Microphysiological System Sales Value, 2020-2031 79
6.5.2 China Microphysiological System Sales Value by Type (%), 2024 VS 2031 80
6.5.3 China Microphysiological System Sales Value by End User, 2024 VS 2031 81
6.6 Japan 82
6.6.1 Japan Microphysiological System Sales Value, 2020-2031 82
6.6.2 Japan Microphysiological System Sales Value by Type (%), 2024 VS 2031 83
6.6.3 Japan Microphysiological System Sales Value by End User, 2024 VS 2031 84
6.7 Southeast Asia 85
6.7.1 Southeast Asia Microphysiological System Sales Value, 2020-2031 85
6.7.2 Southeast Asia Microphysiological System Sales Value by Type (%), 2024 VS 2031 86
6.7.3 Southeast Asia Microphysiological System Sales Value by End User, 2024 VS 2031 87
7 Company Profiles 88
7.1 Emulate 88
7.1.1 Emulate Profile 88
7.1.2 Emulate Main Business 89
7.1.3 Emulate Microphysiological System Products, Services and Solutions 89
7.1.4 Emulate Microphysiological System Revenue (US$ Million) & (2020-2025) 91
7.1.5 Emulate Recent Developments 91
7.2 Mimetas 92
7.2.1 Mimetas Profile 92
7.2.2 Mimetas Main Business 93
7.2.3 Mimetas Microphysiological System Products, Services and Solutions 93
7.2.4 Mimetas Microphysiological System Revenue (US$ Million) & (2020-2025) 95
7.2.5 Mimetas Recent Developments 96
7.3 TissUse 97
7.3.1 TissUse Profile 97
7.3.2 TissUse Main Business 98
7.3.3 TissUse Microphysiological System Products, Services and Solutions 98
7.3.4 TissUse Microphysiological System Revenue (US$ Million) & (2020-2025) 99
7.4 InSphero 99
7.4.1 InSphero Profile 99
7.4.2 InSphero Main Business 100
7.4.3 InSphero Microphysiological System Products, Services and Solutions 100
7.4.4 InSphero Microphysiological System Revenue (US$ Million) & (2020-2025) 104
7.4.5 InSphero Recent Developments 104
7.5 Hesperos 105
7.5.1 Hesperos Profile 105
7.5.2 Hesperos Main Business 106
7.5.3 Hesperos Microphysiological System Products, Services and Solutions 106
7.5.4 Hesperos Microphysiological System Revenue (US$ Million) & (2020-2025) 109
7.5.5 Hesperos Recent Developments 109
7.6 CN Bio 110
7.6.1 CN Bio Profile 110
7.6.2 CN Bio Main Business 110
7.6.3 CN Bio Microphysiological System Products, Services and Solutions 111
7.6.4 CN Bio Microphysiological System Revenue (US$ Million) & (2020-2025) 114
7.6.5 CN Bio Recent Developments 114
7.7 TNO 115
7.7.1 TNO Profile 116
7.7.2 TNO Main Business 116
7.7.3 TNO Microphysiological System Products, Services and Solutions 117
7.7.4 TNO Microphysiological System Revenue (US$ Million) & (2020-2025) 119
7.8 28bio 119
7.8.1 28bio Profile 120
7.8.2 28bio Main Business 120
7.8.3 28bio Microphysiological System Products, Services and Solutions 121
7.8.4 28bio Microphysiological System Revenue (US$ Million) & (2020-2025) 124
7.8.5 28bio Recent Developments 124
7.9 Beijing Daxiang Biotech 125
7.9.1 Beijing Daxiang Biotech Profile 125
7.9.2 Beijing Daxiang Biotech Main Business 126
7.9.3 Beijing Daxiang Biotech Microphysiological System Products, Services and Solutions 126
7.9.4 Beijing Daxiang Biotech Microphysiological System Revenue (US$ Million) & (2020-2025) 128
7.10 Newcells Biotech 129
7.10.1 Newcells Biotech Profile 129
7.10.2 Newcells Biotech Main Business 129
7.10.3 Newcells Biotech Microphysiological System Products, Services and Solutions 130
7.10.4 Newcells Biotech Microphysiological System Revenue (US$ Million) & (2020-2025) 132
7.10.5 Newcells Biotech Recent Developments 132
7.11 Nortis (Quris-Al) 133
7.11.1 Nortis (Quris-Al) Profile 134
7.11.2 Nortis (Quris-Al) Main Business 134
7.11.3 Nortis (Quris-Al) Microphysiological System Products, Services and Solutions 135
7.11.4 Nortis (Quris-Al) Microphysiological System Revenue (US$ Million) & (2020-2025) 136
7.11.5 Nortis (Quris-Al) Recent Developments 137
7.12 Valo Health (TARA Biosystems) 137
7.12.1 Valo Health (TARA Biosystems) Profile 137
7.12.2 Valo Health (TARA Biosystems) Main Business 138
7.12.3 Valo Health (TARA Biosystems) Microphysiological System Products, Services and Solutions 139
7.12.4 Valo Health (TARA Biosystems) Microphysiological System Revenue (US$ Million) & (2020-2025) 140
7.12.5 Valo Health (TARA Biosystems) Recent Developments 140
7.13 Altis Biosystems 141
7.13.1 Altis Biosystems Profile 141
7.13.2 Altis Biosystems Main Business 142
7.13.3 Altis Biosystems Microphysiological System Products, Services and Solutions 143
7.13.4 Altis Biosystems Microphysiological System Revenue (US$ Million) & (2020-2025) 144
7.13.5 Altis Biosystems Recent Developments 145
7.14 Draper Laboratory 145
7.14.1 Draper Laboratory Profile 145
7.14.2 Draper Laboratory Main Business 146
7.14.3 Draper Laboratory Microphysiological System Products, Services and Solutions 147
7.14.4 Draper Laboratory Microphysiological System Revenue (US$ Million) & (2020-2025) 152
7.14.5 Draper Laboratory Recent Developments 152
7.15 Netri 153
7.15.1 Netri Profile 153
7.15.2 Netri Main Business 153
7.15.3 Netri Microphysiological System Products, Services and Solutions 154
7.15.4 Netri Microphysiological System Revenue (US$ Million) & (2020-2025) 156
7.15.5 Netri Recent Developments 157
7.16 Bi/ond 157
7.16.1 Bi/ond Profile 157
7.16.2 Bi/ond Main Business 158
7.16.3 Bi/ond Microphysiological System Products, Services and Solutions 159
7.16.4 Bi/ond Microphysiological System Revenue (US$ Million) & (2020-2025) 161
7.17 ImmuONE 161
7.17.1 ImmuONE Profile 162
7.17.2 ImmuONE Main Business 162
7.17.3 ImmuONE Microphysiological System Products, Services and Solutions 163
7.17.4 ImmuONE Microphysiological System Revenue (US$ Million) & (2020-2025) 165
7.17.5 ImmuONE Recent Developments 165
7.18 AlveoliX 166
7.18.1 AlveoliX Profile 166
7.18.2 AlveoliX Main Business 167
7.18.3 AlveoliX Microphysiological System Products, Services and Solutions 167
7.18.4 AlveoliX Microphysiological System Revenue (US$ Million) & (2020-2025) 170
7.18.5 AlveoliX Recent Developments 170
7.19 Cherry Biotech 171
7.19.1 Cherry Biotech Profile 171
7.19.2 Cherry Biotech Main Business 172
7.19.3 Cherry Biotech Microphysiological System Products, Services and Solutions 172
7.19.4 Cherry Biotech Microphysiological System Revenue (US$ Million) & (2020-2025) 174
7.19.5 Cherry Biotech Recent Developments 174
7.20 Ananda Devices 174
7.20.1 Ananda Devices Profile 175
7.20.2 Ananda Devices Main Business 175
7.20.3 Ananda Devices Microphysiological System Products, Services and Solutions 176
7.20.4 Ananda Devices Microphysiological System Revenue (US$ Million) & (2020-2025) 178
7.20.5 Ananda Devices Recent Developments 178
7.21 Obatala Sciences 179
7.21.1 Obatala Sciences Profile 179
7.21.2 Obatala Sciences Main Business 180
7.21.3 Obatala Sciences Microphysiological System Products, Services and Solutions 180
7.21.4 Obatala Sciences Microphysiological System Revenue (US$ Million) & (2020-2025) 182
7.21.5 Obatala Sciences Recent Developments 182
7.22 BiomimX 183
7.22.1 BiomimX Profile 183
7.22.2 BiomimX Main Business 183
7.22.3 BiomimX Microphysiological System Products, Services and Solutions 184
7.22.4 BiomimX Microphysiological System Revenue (US$ Million) & (2020-2025) 188
7.22.5 BiomimX Recent Developments 188
7.23 React4life 189
7.23.1 React4life Profile 189
7.23.2 React4life Main Business 189
7.23.3 React4life Microphysiological System Products, Services and Solutions 190
7.23.4 React4life Microphysiological System Revenue (US$ Million) & (2020-2025) 192
7.24 Aracari Bio 193
7.24.1 Aracari Bio Profile 193
7.24.2 Aracari Bio Main Business 193
7.24.3 Aracari Bio Microphysiological System Products, Services and Solutions 194
7.24.4 Aracari Bio Microphysiological System Revenue (US$ Million) & (2020-2025) 195
7.25 StemPharm 196
7.25.1 StemPharm Profile 196
7.25.2 StemPharm Main Business 197
7.25.3 StemPharm Microphysiological System Products, Services and Solutions 197
7.25.4 StemPharm Microphysiological System Revenue (US$ Million) & (2020-2025) 198
7.26 SynVivo 199
7.26.1 SynVivo Profile 199
7.26.2 SynVivo Main Business 199
7.26.3 SynVivo Microphysiological System Products, Services and Solutions 200
7.26.4 SynVivo Microphysiological System Revenue (US$ Million) & (2020-2025) 202
7.26.5 SynVivo Recent Developments 202
8 Industry Chain Analysis 204
8.1 Microphysiological System Industrial Chain 204
8.2 Whole Industry Chain Map 204
8.3 Microphysiological System Upstream Analysis 205
8.3.1 Upstream Analysis 205
8.3.2 Raw Materials Key Suppliers 206
8.3.3 Manufacturing Cost Structure 207
8.4 Downstream Analysis (Customers Analysis) 208
8.5 Main Business Model 209
8.6 Sales Model and Sales Channels 210
9 Research Findings and Conclusion 213
10 Appendix 215
10.1 Research Methodology 215
10.1.1 Methodology/Research Approach 215
10.1.2 Data Source 218
10.2 Author Details 221
10.3 Disclaimer 222